We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.5%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.9B
AUM Growth
+$430M
Cap. Flow
-$2.03B
Cap. Flow %
-9.27%
Top 10 Hldgs %
51.69%
Holding
190
New
27
Increased
30
Reduced
39
Closed
32

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$731M
2
HES
Hess
HES
+$436M
3
NDAQ icon
Nasdaq
NDAQ
+$341M
4
SPLK
Splunk Inc
SPLK
+$157M
5
UTHR icon
United Therapeutics
UTHR
+$110M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.9B
2
VMW
VMware, Inc
VMW
+$915M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$770M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$482M
5
AON icon
Aon
AON
+$216M

Sector Composition

Rank Sector Weight
1 Healthcare 27.49%
2 Technology 11.1%
3 Financials 9.67%
4 Industrials 6.16%
5 Communication Services 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
26
Mastercard
MA
$493B
$264M 1.21%
619,471
+13,000
+2% +$5.22M
SHW icon
27
Sherwin-Williams
SHW
$89.8B
$260M 1.19%
832,092
-214,700
-21% -$57.7M
AZN icon
28
AstraZeneca
AZN
$250B
$258M 1.18%
1,912,146
-1,117,631
-37% -$145M
HWM icon
29
Howmet Aerospace
HWM
$112B
$255M 1.17%
4,716,027
-31,600
-0.7% -$1.56M
BX icon
30
Blackstone
BX
$110B
$222M 1.02%
1,697,351
-529,700
-24% -$57.3M
NTRA icon
31
Natera
NTRA
$46.4B
$218M 1%
3,474,883
+1,197,000
+53% +$59.8M
V icon
32
Visa
V
$677B
$208M 0.95%
798,110
+36,700
+5% +$9.05M
SPLK
33
DELISTED
Splunk Inc
SPLK
$202M 0.92%
1,324,000
+1,052,375
+387% +$157M
RVMD icon
34
Revolution Medicines
RVMD
$44B
$193M 0.88%
6,736,854
+3,411,374
+103% +$82M
INSP icon
35
Inspire Medical Systems
INSP
$1.74B
$174M 0.8%
855,096
+429,000
+101% +$69.5M
KRTX
36
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$165M 0.76%
522,000
+519,800
+23,627% +$101M
MASI
37
DELISTED
Masimo
MASI
$154M 0.7%
1,311,649
+1,084,000
+476% +$101M
PTGX icon
38
Protagonist Therapeutics
PTGX
$9.44B
$131M 0.6%
5,734,430
+288,000
+5% +$5.04M
X
39
DELISTED
US Steel
X
$119M 0.55%
2,449,500
+1,814,500
+286% +$66M
MRTX
40
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$119M 0.54%
2,024,472
+1,023,472
+102% +$57.5M
SRPT icon
41
Sarepta Therapeutics
SRPT
$1.77B
$117M 0.53%
1,210,073
-165,127
-12% -$15.8M
VSTS icon
42
Vestis
VSTS
$1.88B
$116M 0.53%
+5,469,753
New +$93.9M
BEAM icon
43
Beam Therapeutics
BEAM
$2.84B
$112M 0.51%
4,105,753
-376,086
-8% -$9.34M
UTHR icon
44
United Therapeutics
UTHR
$23.1B
$105M 0.48%
+476,000
New +$110M
AGIO icon
45
Agios Pharmaceuticals
AGIO
$1.93B
$92.8M 0.42%
4,167,602
+1,416,773
+52% +$31.7M
CYTK icon
46
Cytokinetics
CYTK
$10.4B
$90.8M 0.42%
1,087,772
+1,066,000
+4,896% +$38.6M
ROIV icon
47
Roivant Sciences
ROIV
$26.2B
$82.4M 0.38%
7,336,000
+3,482,600
+90% +$33.9M
IONS icon
48
Ionis Pharmaceuticals
IONS
$9.4B
$78.7M 0.36%
1,555,020
+828,020
+114% +$39.7M
BEKE icon
49
KE Holdings
BEKE
$18.8B
$77.1M 0.35%
4,758,500
– –
EVH icon
50
Evolent Health
EVH
$447M
$71.5M 0.33%
2,163,909
+263,000
+14% +$7.44M
1
2
3 4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Farallon Capital Management held 190 positions worth $21.9B, up 2% from $21.4B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Farallon Capital Management withdrew a net $2.03B in Q4 2023, closing 32 positions and reducing 39 holdings. Its most notable exit was Activision Blizzard, an estimated $1.9B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Pioneer Natural Resource Co. worth $702M.

  • Farallon Capital Management's largest Q4 2023 buy was Pioneer Natural Resource Co.: 3,120,000 shares worth $702M.
  • Farallon Capital Management added most to Nasdaq in Q4 2023, an estimated $341M increase.
  • Farallon Capital Management's biggest Q4 2023 reduction was AstraZeneca, cutting an estimated $145M.
  • Farallon Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.9B.
  • Farallon Capital Management's ten largest holdings make up 52% of its $21.9B portfolio in Q4 2023.
  • Farallon Capital Management opened 27 new positions and closed 32 in Q4 2023.
  • Farallon Capital Management's portfolio value rose 2% quarter-over-quarter to $21.9B.

Based on Farallon Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.